Crohn-betegség: vizsgálatok itt: Egyesült Államok
125 trials · From ClinicalTrials.gov, checked 2026. november 12.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleA Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
- Where
- Anaheim, Ann Arbor, Atlanta, Aurora, Bellevue, Bethesda, Boston, Chapel Hill, Charlotte, Chicago, Clearwater, Clinton Township, Clive, Colorado Springs, Coronado, Dallas, Decatur, Denton, Dothan, Englewood, Evanston, Fort Myers, Great Neck, Gurnee, Hackensack, Hamden, Hershey, Houston, Indianapolis, Inverness, Kansas City, Lakewood, Lancaster, Liberty, Little Rock, Los Angeles, Louisville, Lubbock, Macon, Mansfield, Margate, Mentor, Miami, Middletown, Nashville, New Haven, New York, Oklahoma City, Orange, Orlando, Oxnard, Philadelphia, Phoenix, Port Jefferson, Providence, Richmond, Rochester, San Antonio, San Diego, Seattle, Sioux Falls, Southlake, St Louis, Sun City, Tacoma, Tampa, Topeka, Tucson, Tyler, Uniontown, University Park, Valencia, Washington D.C., Zachary
- Életkor
- 16 év to 80 év
- People
- 1200 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06430801 · EU 2023-508636-61-00 - 3. fázisTaking peopleExtension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
- Where
- Bristol, Charlottesville, Garland, Liberty, Lubbock, New York, San Antonio, Southlake, Tacoma, Tyler, Ypsilanti
- Életkor
- 18 év and over
- People
- 1380 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06651281 · EU 2024-513533-20-00 - No phaseTaking peopleLongitudinal Immunophenotyping of Patients With Inflammatory Bowel Disease
- Where
- Bethesda
- Életkor
- 18 év to 85 év
- People
- 100
- Run by
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
See details and how to joinNCT07619547 - 4. fázisTaking peopleIron Treatment for Iron Deficiency Anemia in Children and Young Adults With Crohn's Disease
- Where
- New York
- Életkor
- 3 év to 21 év
- People
- 150
- Run by
- Weill Medical College of Cornell University
See details and how to joinNCT07925450 - 2. fázisNot yet taking people in Egyesült ÁllamokOral N-acetylglucosamine in Crohn's Disease
- Where
- Baltimore
- Életkor
- 18 év to 80 év
- People
- 40
- Run by
- Johns Hopkins University
See details and how to joinNCT07225998 - 3. fázisTaking peopleA Study to Assess the Pharmacokinetics, Effectiveness and Safety of Afimkibart for Induction and Maintenance Therapy in Children With Moderately to Severely Active Crohn's Disease
- Where
- Harlingen, New York
- Életkor
- 2 év to 17 év
- People
- 100 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07298421 · EU 2025-523318-96-00 - 2. fázisTaking peopleA Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
- Where
- Atlanta, Bridgeton, Cedar Park, Colorado Springs, Denton, Fayetteville, High Point, Houma, Houston, Johnson City, Kissimmee, Lancaster, Lewisville, Lynchburg, Mansfield, Miami, North Las Vegas, Ogden, Orlando, Palmetto Bay, Raleigh, San Diego, Summerville, Tyler
- Életkor
- 18 év to 85 év
- People
- 385 worldwide
- Run by
- Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)
See details and how to joinNCT06226883 · EU 2023-508158-24-00 - 3. fázisTaking peopleMirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
- Where
- Anaheim, Beverly Hills, Chevy Chase, Chicago, Cordova, Dothan, Fayetteville, Greenville, Idaho Falls, Indianapolis, Lebanon, Los Alamitos, Louisville, Miami, Milwaukee, New Albany, New Bedford, New Iberia, New York, Northridge, Orlando, Pensacola, Philadelphia, Providence, San Antonio, Shreveport, St Louis, Sunrise, Tacoma, Tyler, Westlake, Yonkers
- Életkor
- 18 év to 70 év
- People
- 290 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT06937099 · EU 2024-520210-21-00 - 2. fázisTaking peopleA Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
- Where
- Atlanta, Chicago, Englewood, Kingwood, Las Vegas, Los Angeles, Miami, Miami Lakes, Oxnard, San Antonio, Scottsdale, St Louis, Topeka, Wyoming
- Életkor
- 18 év to 80 év
- People
- 60 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07483073 · EU 2025-524112-11-00 - 2. fázisTaking peopleA Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease
- Where
- Atlanta, Chicago, Englewood, Kingwood, Las Vegas, Los Angeles, Miami, Miami Lakes, Oxnard, San Antonio, Scottsdale, St Louis, Topeka, Wyoming
- Életkor
- 18 év to 80 év
- People
- 60 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07483099 - No phaseTaking peopleA Study to Assess the Long-Term Safety of Ustekinumab Versus Other Biologics in Patients With Crohn's Disease and Ulcerative Colitis
- Where
- Houston
- Életkor
- 18 év and over
- People
- 1536
- Run by
- Janssen Scientific Affairs, LLC
See details and how to joinNCT04372108 - 3. fázisTaking peopleA Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease
- Where
- Atlanta, Boston, Colchester, Dayton, Fort Worth, Hartford, Indianapolis, Los Angeles, Morristown, New York, Philadelphia
- Életkor
- 2 év to 17 év
- People
- 120 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT05923073 · EU 2023-504735-41-00 - 3. fázisTaking peopleA Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
- Where
- Atlanta, Cincinnati, Fort Worth, Indianapolis, Salt Lake City
- Életkor
- 3 év to 64 év
- People
- 196 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT06663332 · EU 2023-509560-16-00 - 2/3. fázisTaking peopleA Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
- Where
- Anaheim, Atlanta, Austin, Canoga Park, Carmel, Carrollton, Chandler, Chapel Hill, Charleston, Charlotte, Chesapeake, Chevy Chase, Colorado Springs, Coronado, Crestview Hills, Cutler Bay, Dallas, Danbury, Glen Burnie, Harrisburg, Hershey, Houston, Indianapolis, Inverness, Jacksonville, Lafayette, Lakewood Rch, Lancaster, Litchfield Park, Los Angeles, Louisville, Lynchburg, Macon, Miami, Milwaukee, Newport Beach, New York, Oklahoma City, Oxnard, Philadelphia, Portland, Providence, Rochester, Rock Hill, San Antonio, San Diego, San Francisco, Scottsdale, Southlake, Tacoma, Tampa, Tyler, West Monroe, Wichita
- Életkor
- 18 év and over
- People
- 1092 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT07196722 · EU 2025-521382-27-00 - No phaseCsak meghívásosPartial Enteral Nutrition as Therapeutic Augmentation of Advanced Pharmacological Therapy in Patients With Active Crohn's Disease
- Where
- Austin, Beverly Hills, Chapel Hill, New Brunswick, Philadelphia
- Életkor
- 18 év to 80 év
- People
- 80
- Run by
- James Lewis
See details and how to joinNCT07356232 - 3. fázisTaking peopleA Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
- Where
- Anaheim, Atlanta, Carmel, Carrollton, Chapel Hill, Charlotte, Clive, Colorado Springs, Dothan, Farmington Hills, Glen Burnie, Hamden, Jacksonville, Lafayette, Lancaster, Los Alamitos, Los Angeles, Lubbock, Macon, Mentor, Miami, Mobile, Naples, New Bedford, New York, Northbrook, Oklahoma City, Orlando, San Antonio, San Diego, Shreveport, Summerville, Tampa, Topeka, Tyler, Uniontown
- Életkor
- 18 év and over
- People
- 530 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT07499232 - 3. fázisTaking peopleA Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease
- Where
- Anaheim, Chapel Hill, Chula Vista, Colorado Springs, Cordova, Crestview Hills, Farmington Hill, Lafayette, Lakewood Rch, Lee's Summit, Los Alamitos, Mentor, Metairie, Miami, New York, Oklahoma City, Orlando, Portland, Richmond, Rochester, San Diego, Scottsdale, Summerville, Sun City, Suwanee, Tacoma, Tampa, Tyler, Webster
- Életkor
- 18 év and over
- People
- 460 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT07577843 · EU 2026-525922-39-00 - 4. fázisTaking peopleA Remotely Conducted Study to Assess Concentration of TREMFYA in Breast Milk of Lactating Women Who Are Receiving TREMFYA Therapeutically
- Where
- Chapel Hill
- Életkor
- 18 év and over
- People
- 10
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT07654751 - 2. fázisTaking peopleA Study of SL-325 in Crohn's Disease Patients
- Where
- Boston, Cincinnati, Columbus, Glen Burnie, Houma, Inverness, Kansas City, Kissimmee, Liberty, Little Rock, Marrero, Maspeth, Naples, Nashville, Orlando, Oxnard, St Louis, Tampa, Temple City, West Hills
- Életkor
- 18 év to 80 év
- People
- 232
- Run by
- Shattuck Labs, Inc.
See details and how to joinNCT07753850 - 1/2. fázisTaking peopleAn Open-Label, Proof of Consent Study of Vorinostat for the Treatment of Mdoerate-to-Severe Crohn s Disease and Maintenance Therapy With Ustekinumab
- Where
- Bethesda
- Életkor
- 18 év to 65 év
- People
- 35
- Run by
- National Institute of Allergy and Infectious Diseases (NIAID)
See details and how to joinNCT03167437 - 2. fázisTaking peopleA Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
- Where
- Atlanta, Bellaire, Clearwater, Dallas, Decatur, Fort Worth, Glen Burnie, Greenville, Iowa City, Kansas City, Kingwood, Lakeland, Las Vegas, Liberty, Louisville, Mansfield, Mentor, Miami Lakes, Murrieta, Naples, New York, Oklahoma City, Orange, Orlando, Providence, Rochester, San Antonio, Seattle, Tampa, Tyler
- Életkor
- 18 év to 75 év
- People
- 268 worldwide
- Run by
- Takeda
See details and how to joinNCT06233461 · EU 2023-506704-14-00 - 2. fázisTaking peopleA Study to Investigate Efficacy and Safety of Brivekimig in Participants With Crohn's Disease
- Where
- Boston, Chapel Hill, Colorado Springs, Escondido, Fairhope, Fredericksburg, Harrisburg, Houston, Iowa City, Kansas City, Kissimmee, Lancaster, Lighthouse PT, Marietta, Miami, Ogden, Orlando, Palmetto Bay, Richmond, San Diego, St Louis, Tucson, Wyoming
- Életkor
- 18 év to 75 év
- People
- 99 worldwide
- Run by
- Sanofi
See details and how to joinNCT06958536 · EU 2024-517016-30-00 - No phaseTaking peopleALPCO Calprotectin CLIA Assay - Measurement of Calprotectin Levels in Human Stool
- Where
- Miami, Salem, Westlake
- Életkor
- 22 év and over
- People
- 1000
- Run by
- American Laboratory Products Company
See details and how to joinNCT06810518 - 2. fázisTaking peopleNOV-ERA - A Clinical Trial to Assess the Efficacy and Safety of Ontunisertib Compared to Placebo in Patients With Fibrostenosing Crohn's Disease
- Where
- Albany, Bradenton, Cedar Park, Fort Worth, Georgetown, Providence, Sun City
- Életkor
- 18 év and over
- People
- 320 worldwide
- Run by
- Agomab Spain S.L.U.
See details and how to joinNCT07683325 - 4. fázisCsak meghívásosINSIGHT-IBD Pragmatic Study
- Where
- Cedar Park, Fort Worth, Glenview, Gurnee, Houston, Indianapolis, Plano, Richmond, Rochester, San Antonio, San Marcos, Sun City, Tucson
- Életkor
- 21 év and over
- People
- 400
- Run by
- Specialty Networks Research.
See details and how to joinNCT07686757